Analysts Upgraded These Healthcare Stocks Last Week

Stock analysts upgraded shares in the Healthcare sector for the week ending December 16th, 2011:

Edwards Lifesciences (NYSE:EW): Canaccord Genuity upgraded its rating on this company from Hold to Buy and changed its price target to $75 on Dec 12th. The shares recently traded at $67.60, down $0.25, or 0.37% since the analyst’s rating. About the company: Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company’s products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide. Get the most recent company news and stock data here >>

ViroPharma (NASDAQ:VPHM): WBB Securities upgraded its rating on this company from Buy to Strong Buy and changed its price target from $24.5 to $31.25 on Dec 15th. The shares recently traded at $27.21, down $0.59, or 2.12% since the analyst’s rating. About the company: ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company’s products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (NYSE:CDI) and enterocolitis. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>